The World Health Organization (WHO) prequalified Coartem Baby (artemether-lumefantrine) on April 24, making it the first antimalarial treatment developed specifically for newborns and young infants weighing between 2 and 5 kilograms.
WHO Approves First Malaria Drug Made for Newborns